SEC CIK 1810882
Lebwohl David
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NTLAview stock → | 131,192 | 2026-03-01 |
Position History — NTLA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NTLA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-03-01 | Grant / award (derivative) | 14,204 | $0.00 | 14,204 |
| 2026-03-01 | Grant / award | 9,943 | $0.00 | 131,192 |
| 2026-01-05 | Open-market sale | 11,903 | $9.21 | 121,249 |
| 2025-03-01 | Grant / award (derivative) | 61,714 | $0.00 | 61,714 |
| 2025-03-01 | Grant / award | 43,200 | $0.00 | 130,866 |
| 2025-01-03 | Open-market sale | 9,557 | $12.18 | 87,666 |
| 2025-01-01 | Option exercise (derivative) | 3,189 | $0.00 | 0 |
| 2025-01-01 | Option exercise | 3,189 | — | 97,223 |
| 2024-03-01 | Grant / award (derivative) | 55,855 | $0.00 | 55,855 |
| 2024-03-01 | Grant / award | 38,701 | $0.00 | 93,073 |
| 2024-01-03 | Open-market sale | 5,843 | $29.46 | 54,372 |
| 2024-01-01 | Option exercise (derivative) | 3,187 | $0.00 | 3,189 |
| 2024-01-01 | Option exercise | 3,187 | — | 60,215 |
| 2023-03-01 | Grant / award (derivative) | 43,342 | $0.00 | 43,342 |
| 2023-03-01 | Grant / award | 30,674 | $0.00 | 56,361 |
| 2023-01-04 | Open-market sale | 2,574 | $37.21 | 25,687 |
| 2023-01-01 | Option exercise (derivative) | 3,187 | $0.00 | 6,376 |
| 2023-01-01 | Option exercise | 3,187 | — | 28,261 |
| 2022-03-01 | Grant / award (derivative) | 13,816 | $0.00 | 13,816 |
| 2022-03-01 | Grant / award | 13,816 | $0.00 | 24,738 |
| 2022-03-01 | Grant / award (derivative) | 20,203 | $0.00 | 20,203 |
| 2022-01-01 | Option exercise (derivative) | 3,187 | $0.00 | 9,563 |
| 2022-01-01 | Option exercise | 3,187 | — | 11,973 |
| 2022-01-01 | Open-market sale | 1,051 | $112.24 | 10,922 |
| 2021-11-05 | Option exercise (derivative) | 2,400 | $0.00 | 180,077 |
| 2021-11-05 | Open-market sale | 1,200 | $131.71 | 9,914 |
| 2021-11-05 | Option exercise | 2,400 | $12.62 | 11,114 |
| 2021-11-05 | Open-market sale | 548 | $134.07 | 8,914 |
| 2021-11-05 | Open-market sale | 200 | $135.34 | 8,714 |
| 2021-11-05 | Open-market sale | 452 | $132.62 | 9,462 |
| 2021-10-14 | Option exercise (derivative) | 2,400 | $0.00 | 182,477 |
| 2021-10-14 | Option exercise | 2,400 | $12.62 | 11,114 |
| 2021-10-14 | Open-market sale | 849 | $127.81 | 9,714 |
| 2021-10-14 | Open-market sale | 225 | $129.01 | 9,489 |
| 2021-10-14 | Open-market sale | 525 | $129.83 | 8,964 |
| 2021-10-14 | Open-market sale | 250 | $130.47 | 8,714 |
| 2021-10-14 | Open-market sale | 551 | $126.92 | 10,563 |
| 2021-09-24 | Option exercise (derivative) | 7,923 | $0.00 | 184,877 |
| 2021-09-24 | Option exercise | 7,923 | $12.62 | 8,714 |
| 2021-09-21 | Option exercise (derivative) | 2,400 | $0.00 | 192,800 |
| 2021-09-21 | Option exercise | 2,400 | $12.62 | 3,191 |
| 2021-09-21 | Open-market sale | 2,400 | $149.81 | 791 |
| 2021-08-30 | Option exercise (derivative) | 2,400 | $0.00 | 195,200 |
| 2021-08-30 | Open-market sale | 700 | $156.70 | 2,291 |
| 2021-08-30 | Open-market sale | 1,100 | $159.19 | 941 |
| 2021-08-30 | Open-market sale | 250 | $157.60 | 2,041 |
| 2021-08-30 | Open-market sale | 150 | $160.10 | 791 |
| 2021-08-30 | Open-market sale | 200 | $155.43 | 2,991 |
| 2021-08-30 | Option exercise | 2,400 | $12.62 | 3,191 |
| 2021-08-09 | Option exercise (derivative) | 2,400 | $0.00 | 197,600 |
| 2021-08-09 | Open-market sale | 2,400 | $164.05 | 791 |
| 2021-08-09 | Option exercise | 2,400 | $12.62 | 3,191 |
| 2021-03-03 | Grant / award (derivative) | 12,750 | $0.00 | 12,750 |
| 2021-03-03 | Grant / award (derivative) | 76,500 | $0.00 | 76,500 |
| 2020-05-01 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.